Anesthesia and Respiratory Devices Market Revenue, Diagnostic Testing Volume, Adoption Rates, Pricing Metrics, Supply Chain Performance, Market Share Analysis, and Innovation Trends

Revenue, 2025

USD 50.45 Bn

Forecast Year, 2035

USD 95.26 Bn

CAGR, 2026 - 2035

6.56%

Report Coverage

Global

What is Anesthesia and Respiratory Devices Market Size?

The global anesthesia and respiratory devices market size was estimated at USD 50.45 billion in 2025 and is predicted to reach around USD 95.26 billion by 2035, registering a CAGR of 6.56% from 2026 to 2035. The growth of the anesthesia and respiratory devices market is expected to expand rapidly in the coming years due to the increasing surgical procedures and rising cases of respiratory disorders. Anesthesia and respiratory devices provide better care to patients with serious and chronic respiratory diseases. These devices are designed to deliver adequate amounts of anesthetic gases to keep patients unconscious during surgery.

Market Highlights

• North America has held the highest revenue share of 26% in 2025.
• Asia-Pacific is anticipated to expand at the fastest CAGR during the forecast period.
• By Product, the respiratory devices segment dominated the global market in 2025.

Market Size and Forecast

• Market Size in 2025: USD 50.42 Billion
• Market Size in 2026: USD 53.73 Billion
• Forecasted Market Size by 2035: USD 95.26 Billion
• CAGR (2026-2035): 6.56%
• Largest Market in 2025: North America
• Fastest Growing Market: Asia Pacific

AI's Role in the Anesthesia and Respiratory Devices Market

Artificial intelligence in this market incorporates smart expertise leading in the healthcare sector. The changing dynamics in the medical field with advanced therapies are proactively highlighting the need for AI to drive automation in the market spectrum. AI-sponsored tools are a huge support to clinicians for them to manage treatment timelines. The comprehensive closed-loop systems unify with blood pressure and EEG. The brilliance of AI improves accuracy and safety in the responsible devices sector. The AI platforms have smartly served medical practices focusing on respiratory and anesthesia. The technology contributes largely to sedation management and marks excellence in care delivery. The boost to computational power enhances workflow and patient outcomes. AI-fuelled systems contribute to direct patient care, featuring the advancement to the market. In association with the combatting platforms and systems like intelligent drug management platforms and logistics robots is a perk to the AI-influenced model, driving valuable growth and expansion to the market.

Anesthesia and Respiratory Devices Market Growth Factors

• A significant rise in the number of surgical procedures boosts the demand for anesthesia devices to deliver anesthetic drugs. Anesthetics prevent pain during surgery by blocking the nerves from transmitting pain signals to the brain. Because the effects of local anesthesia are short-lived, healthcare often uses it for minor surgeries.
• The growing frequency of respiratory illnesses, such as chronic obstructive pulmonary disease (COPD and obstructive sleep apnea (OSA), propels the growth of the market. Respiratory devices clear mucus from the lungs. This further helps prevent pneumonia.
• The growing awareness about respiratory health contributes to market expansion.
• Rising advancements in medical devices lead to the development of user-friendly devices, which support the market's growth.
• The increasing occurrence of respiratory infections is anticipated to boost the growth of the market.
• The inclination toward home-based oxygen therapy boosts the demand for respiratory devices.
• The increasing geriatric population worldwide further contributes to market growth, as older adults are more prone to respiratory complications.

Market Scope

Market Dynamics

Drivers

Increasing Number of Surgical Procedures Among Geriatric People

The increasing number of surgical procedures in elderly patients, who are at higher risk of perioperative morbidity and mortality due to age-related physiological and pathological changes, is driving the growth of the anesthesia and respiratory devices market. As older adults are more sensitive to anesthesia and require long-term physical and respiratory support, they require adequate amounts of anesthetic drugs to reduce overdosing and associated side effects. However, anesthesia devices play a crucial role during surgery to administer adequate amounts of anesthetic drugs, further improving the outcomes of elderly patients. Elderly patients receiving anesthesia, especially after endotracheal intubation, face a high risk of lower respiratory tract infections, boosting the need for anesthesia and respiratory devices.

Restraint

Complexity of Modern Anesthesia Machines

The complexity of modern anesthesia machines has limited the adoption of anesthesia and respiratory devices. Significant investments need to be made in research and development as these systems evolve from simple devices used to anesthetize and oxygenate patients to sophisticated systems that include complex ventilators, end-tidal carbon dioxide monitors, anesthetic concentration monitors, and vital sign monitoring. In addition, the high level of complexity can increase manufacturing costs and potentially limit their affordability and accessibility, especially in medical facilities in low-income countries. The need for specialized training to operate these devices also limits their widespread use, further hindering market growth.

Opportunity

Advancements in Integrated Anesthesia Workstation

The emergence of modern anesthesia clinics presents a great opportunity for the growth of the anesthesia and respiratory devices market. These cutting-edge systems combine high-pressure heating, gas delivery, drug vaporization, and patient care in a single, cohesive platform, providing greater precision and control during anesthesia. The integration of precise high-precision sensors, electronically controlled flow valves, and advanced software enables high-quality gas delivery and optimized inhalant use, leading to cost-effective processes. Furthermore, integrating low-level and closed-circuit anesthesia systems with anesthesia information provides significant benefits in patient safety and management. This technological advancement not only improves the quality of anesthesia care but also creates lucrative growth opportunities for companies competing in the market.

Segment Insights

Product Insights

Anesthesia devices segment dominated the market in 2025 with its remarkable performance and heavy deployment of machines like workstations, ventilators, monitors, disposables and delivery machines. The growing breathing problems and operations are elevating hospital visits, expanding the need for system-integrated devices. The advanced anesthesia workstations and other operative tools are bolstering the treatments and perioperative care, focusing on patients' experience with the therapy and care.

The respiratory devices segment is expected to grow during the forecast period. The rising use and sale of disposable oxygen masks is strengthening the base of the segmental market. The different equipment deployment in layers of the perioperative process drives value in the market. The rapid involvement of inhalers and nebulizers in the hard-to-breathe population expands demand for the devices as well.

Regional Insights

Why Does North America Dominate the Global Anesthesia & Respiratory Devices Market?

In 2025, North America dominated the global anesthesia & respiratory devices market and is expected to reflect this trend throughout forecast period. The anesthesia and respiratory devices market in the U.S.is predicted to grow, as the number of patients undergoing from COPD is mounting quickly. It is expected that nearby 12 million people are suffering from COPD in the U.S. Growing senior population, more number of casualty surgeries accomplished and accessibility of reimbursement for respiratory and anesthesia devices are the reasons that are positively impacting market growth in the U.S.

U.S. Anesthesia and Respiratory Devices Market Size and Growth 2026 to 2035

The U.S. anesthesia and respiratory devices market size was valued at USD 9.21 billion in 2025 and is estimated to reach around USD 18.42 billion by 2035, growing at a CAGR of 7.18% from 2026 to 2035.

Why Is Asia Pacific Emerging as a High-Growth Market for Anesthesia & Respiratory Devices?

Asia Pacific, Japan accounted for the major share of the market on account of substantial rise in the elderly population. Emerging nations such as China and India are also projected to observe a noteworthy population suffering from pulmonary diseases. As per the data released by World Health Organization (WHO), nearby 90% of the deaths credited to COPD occur in middle-income and low nations. Likewise, as per the study circulated in the International Journal of Pulmonary and Respiratory Sciences, in India, COPD was the second biggest reason of death in 2016. Thus, rising cases of respiratory diseases across emerging countries is anticipated to further propel the growth of anesthesia & respiratory devices market in the Asia Pacific.

Europe's Advancements in the Market

Europe's anesthesia and respiratory devices market is considered to be a significantly growing area, due to intelligent cooperative high-performance system devices that sharpen the value of the robust devices that align with the healthcare industry values. The growing homecare trend is accelerating the sales and demand for the miniaturized home-use models. Following this, sustainability is visibly promoting the eco-friendly possibilities or aspects supporting the market value. The healthcare manufacturers are smartly introducing anesthesia space for the tech and systems unification. The accuracy in dosing is a safety for patient care.

Latin America's Innovative Step in the Market

Latin America market is considered to be a significantly growing area due to the innovation that has been consistent in the software and high-tech enhancements that feature efforts in the countries' dynamic advancements. AI-sponsored vital sign monitoring and software as a medical device are strongly gaining traction in the regional market innovations. The comprehensive healthcare infrastructure enables the leaders to deploy promising devices in the cooperative and suitable spaces.

MEA's Initiatives in the Market

MEA's anesthesia and respiratory devices market is considered to be a significantly growing area, due to the government's backing that supports long-term sincere developmental growth in the regional market. Saudi Arabia is known for its heavy spending on digital health and hospital architecture to promote the advanced ecosystem. The Saudi Vision 2030 Healthcare is elevating the tech spirit and general manufacturing. The expanding trauma centers are bolstering the public investments that ultimately drive commendable reach to the regional market.

Anesthesia and Respiratory Devices Market Companies

• Masimo Corporation
• Medtronic
• AirSep Corporation
• Smiths Medical
• GE Healthcare
• Philips Healthcare
• Braun Medical Inc.
• Drägerwerk AG & Co
• KGaA
• Getinge AB
• Teleflex Inc

Recent Developments

• In October 2023, AirLife, a leading manufacturer and distributor of medical devices for anesthesia and respiratory care in North American, announced the completion of its respiratory business: BALLARD, MICROCUFF, and endOclear product lines, from Avanos Medical, Inc. The acquisition enables AirLife to enhance its product portfolio of anesthesia and respiratory care.
• In June 2023, Avanos Medical, Inc. agreed to sell its Regenerative Medicine (RH) business to SunMed Group Holdings, LLC (SunMed), a leading North American manufacturer and distributor of consumable medical devices for anesthesia and respiratory care.
• In March 2023, SunMed, a leading North American manufacturer and distributor of medical devices for anesthesia and respiratory care, announced a definitive agreement with Vyaire Medical, under which SunMed will acquire Vyaire's business, which manufactures and sells respiratory and anesthesia supplies for airway management and surgical treatment.

Segments Covered in the Report

By Product

• Anesthesia Devices
  • Machines
    • Workstations
    • Monitors
    • Ventilators
    • Delivery machines
      • Standalone
      • Portable
    • Disposables
      • Disposable Accessories
      • Disposable Masks
• Respiratory Devices
  • Disposables
    • Disposable Oxygen Masks
    • Resuscitators
    • Tracheostomy Tubes
    • Oxygen Cannula
  • Equipment
    • Reusable Resuscitators
    • Ventilators
      • Adult Ventilators
      • Neonatal ventilators
    • Positive Airway Pressure
      • Bi-level positive airway pressure devices
      • Continuous positive airway pressure devices
    • Nebulizers
      • Pneumatic nebulizers
      • Mesh nebulizers
      • Ultrasonic nebulizers
    • Inhalers
      • Dry powdered inhalers
      • Metered-dose inhaler
    • Humidifiers
      • Heat exchangers
      • Pass over humidifiers
      • Heat humidifiers
      • Heated wire breathing circuits
    • Oxygen Concentrators
      • Portable oxygen concentrators
      • Fixed oxygen concentrators
    • Measurement Devices
      • Spirometers
      • Pulse Oximeters
      • Capnography
      • Peak Flow Meters

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa